Anti Human CD30 Therapeutic Antibody 2

Brentuximab vedotin (TAB-153) DESCRIPTION CATALOG # SIZE Anti-Human CD30 Therapeutic Antibody TAB-153 1mg PRODUCT INFORMATION  Product Overview  Recombinant monoclonal antibody to CD30. Brentuximab vedotin is an antibody- drug conjugate (ADC) directed to... More

Brentuximab vedotin (TAB-153) DESCRIPTION CATALOG # SIZE Anti-Human CD30 Therapeutic Antibody TAB-153 1mg PRODUCT INFORMATION  Product Overview  Recombinant monoclonal antibody to CD30. Brentuximab vedotin is an antibody- drug conjugate (ADC) directed to the protein CD30, which is expressed in classical Hodgkin lymphoma (HL) and systemic anaplastic large cell lymphoma (sALCL).  Target  CD30  Type  IgG1 - kappa  Immunogen  Hodgkin"s lymphoma cell line L428.  Species Reactivity  Human  Expression Host  CHO  Applications  Suitable for use in Neut, ELISA, IF, IP, FuncS, FC, ICC and most other immunological methods.  Specificity  Tested positive against native human antigen.  Protein Construction  Immunoglobulin G1, anti-(human CD30 (antigen)) (human-mouse monoclonal cAC10 γ1-chain), disulfide with human-mouse monoclonal cAC10 Kappa-chain, dimer, complex withN-[[[4-[[N-[6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]-L-valyl-N5- (aminocarbonyl)-L-ornithyl]amino]phenyl Less